ArticleBMC public health2025
Predicting cardiovascular disease among diabetic patients in Ethiopia using machine learning models: evidence from Ethiopian public health Institute data (2024/2025).
Article in BMC public health, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
5 citing papers in PubMed.
- Beyond prescriptions: an analysis of patient journey, self-management adherence, and unmet needs in type 2 diabetes.BMC health services research · 2026Article
- An online interpretable machine learning model for predicting cardiometabolic multimorbidity risk in patients with type 2 diabetes mellitus.Scientific reports · 2026Article
- Artificial intelligence approaches to predicting treatment non-adherence in chronic diseases: a narrative review.Frontiers in digital health · 2026Review
- Development and external validation of an interpretable machine learning model for diagnosing coronary heart disease in patients with type 2 diabetes and MASLD.Frontiers in endocrinology · 2026Article
- Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
introductionCardiovascular disease (CVD) is the leading cause of death among individuals with diabetes, accounting for nearly 50% of diabetes-related mortality. In Ethiopia, the burden of diabetes is increasing, yet there is a lack of predictive tools for identifying those at highest risk of developing CVD. In Ethiopia recent studies report a CVD prevalence of 37.26% among diabetic patients. This study employed machine earning to predict CVD among Ethiopia diabetic patients using Ethiopian public Health Institute (EPHI) datasets, with a focus on identifying the most influential risk factors for public health decision-making.
objectiveThe main objective of this study is to predict CVD among diabetic patients in Ethiopia using machine learning techniques.
methodThe dataset comprised of 9030 instances with 22 features sourced from Ethiopian Public Health Institute. This prediction of cardiovascular disease (CVD) incorporated socio-demographic, behavioral, and clinical measurement data. Logistic regression, decision tree, Support Vector Machine, Random forest, Gradient boosting machine and artificial neural network were employed. Those models were trained on 80% of the data and tested on the remaining 20%. The analysis was conducted with python using 3.10.
resultsAccording to the results analyzed, Gradient Boosting Model (GBM) demonstrated the highest overall performance, achieving an accuracy of 93%, followed closely by Logistic Regression (LR) with 90% accuracy. In terms of precision, GBM and LR performed comparably, while the LR achieved the highest recall at 88%. Regarding the F1 score, GBM attained 82%, indicating a strong balance between precision and recall. Additionally, the receiver operating characteristics (ROC) analysis showed that GBM had the largest area under the curve (AUC) of 0.96, reflecting superior descriptive ability 0.96.
conclusionThe gradient boosting machine (GBM) model demonstrated the highest performance compared to the other models, achieving an accuracy of 93%. The most significant factors influencing the GBM model were total cholesterol, hypertension, and fasting blood glucose levels. The gradient boosting model shows potential for future integration into clinical decision-support systems, pending external validation and early prediction of cardiovascular disease in individuals with diabetes.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.